Short Bowel Syndrome Market volume is estimated to 2.67 billion by 2020; Finds New Report

Short Bowel Syndrome - Market Insights, Epidemiology and Market Size Forecast-2020 Reports provides an overview of the disease and global market size of the Short Bowel Syndrome for the 7MM (United States, EU5 (France, Germany, Italy, Spain and UK) and Japan). It also includes global historical and forecasted epidemiological data for the diagnosed incident cases of Short Bowel Syndrome from 2010-2020.

Short-bowel syndrome is a disorder clinically defined by malabsorption, diarrhea, steatorrhea, fluid and electrolyte disturbances, and malnutrition.People with short bowel syndrome cannot absorb enough water, vitamins, and other nutrients from food to sustain life. The treatment options are complex and varied. The specific treatment plan may be highly individualized and can include Total Parental Nutrition (TPN) support, which involves use of oral rehydration solutions, parenteral nutrition and enteral nutrition. Gattex (Teduglutide) is currently the first non-surgical treatment for short bowel syndrome (SBS), which is predicted to improve the daily, lives of the patients and is the third approved therapy by USFDA. The drug is going to be the best selling drug worldwide throughout the forecast period.According to Publisher, the forecasted patient population of SBS will increaseat a CAGR of 1.17% from 2015 to 2020 and the worldwide SBS market is estimated to be 2.67 billion by 2020.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Scope

• Report covers the disease overview including etiology, pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2010-2020.
• It also provides Market size of Short Bowel Syndrome for United States, EU5 and Japan from 2010 and forecasted Market size to 2020

Spanning over 70 pages “Short Bowel Syndrome - Market Insights, Epidemiology and Market Size Forecast-2020” report covers Short Bowel syndrome, Disease overview, Pathophysiology, Symptoms of disease, Appendix, Report Methodology.

For more information Visit at: http://mrr.cm/JkY

Related Reports:

Respiratory syncytial virus (RSV) - Market Insights, Epidemiology and Market Size Forecast-2020 - Visit at - http://mrr.cm/Jkg

Ulcerative Colitis (UC) - Market Insights, Epidemiology and Market Size Forecast-2020 - Visit at - http://mrr.cm/JkM